相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MAFG-driven astrocytes promote CNS inflammation
Michael A. Wheeler et al.
NATURE (2020)
The Role of Astrocytes in CNS Inflammation
Federico Giovannoni et al.
TRENDS IN IMMUNOLOGY (2020)
Astrocyte Crosstalk in CNS Inflammation
Mathias Linnerbauer et al.
NEURON (2020)
Regulation of Astrocyte Functions in Multiple Sclerosis
Michael A. Wheeler et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity
Martina Ott et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
Maisa C. Takenaka et al.
NATURE NEUROSCIENCE (2019)
Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences
Anqi Zhu et al.
BIOINFORMATICS (2019)
Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation
Michael A. Wheeler et al.
CELL (2019)
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS
Chun-Cheih Chao et al.
CELL (2019)
The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease
Veit Rothhammer et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
Cristina Gutierrez-Vazquez et al.
IMMUNITY (2018)
Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
Anna T. Wilmes et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
Antonietta Gentile et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Microglial control of astrocytes in response to microbial metabolites
Veit Rothhammer et al.
NATURE (2018)
Multiple Sclerosis: Mechanisms and Immunotherapy
Clare Baecher-Allan et al.
NEURON (2018)
Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development
Ilia D. Vainchtein et al.
SCIENCE (2018)
In vitro toxicity and in silico docking analysis of two novel selective AH-receptor modulators
Selma Mahiout et al.
TOXICOLOGY IN VITRO (2018)
Detection of aryl hydrocarbon receptor agonists in human samples
Veit Rothhammer et al.
SCIENTIFIC REPORTS (2018)
Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies
Gwendoline Montes Diaz et al.
AUTOIMMUNITY REVIEWS (2018)
Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
Susan H. Smith et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS
Veit Rothhammer et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor
Johannes Berg et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
Veit Rothhammer et al.
NATURE MEDICINE (2016)
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
Joel Kaye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2
Ada Yeste et al.
SCIENCE SIGNALING (2016)
Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2
Ada Yeste et al.
SCIENCE SIGNALING (2016)
Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression
Michel Varrin-Doyer et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Bernhard Hemmer et al.
LANCET NEUROLOGY (2015)
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
T. L. Vollmer et al.
JOURNAL OF NEUROLOGY (2014)
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
Massimo Filippi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Lior Mayo et al.
NATURE MEDICINE (2014)
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
Manoj Kumar Mishra et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis
Elias Toubi et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
Rina Aharoni et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Aiolos promotes TH17 differentiation by directly silencing Il2 expression
Francisco J. Quintana et al.
NATURE IMMUNOLOGY (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
Ulf Schulze-Topphoff et al.
PLOS ONE (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling
Henry Yim Wu et al.
PLOS ONE (2011)
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
Christiane Wegner et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27
Lionel Apetoh et al.
NATURE IMMUNOLOGY (2010)
An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis
Francisco J. Quintana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
G. Comi et al.
LANCET (2008)
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Francisco J. Quintana et al.
NATURE (2008)
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-β in Lewis rats
HS Yang et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
分享论文
